Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barré syndrome
Abstract The global burden of Guillain-Barré syndrome (GBS), an immune-mediated neuropathy, remains poorly characterized during the COVID-19 pandemic. We analyzed age-standardized years lived with disability (YLD) for GBS from 1990 to 2021 using GBD 2021 data and COVID-19 vaccination coverage from O...
Saved in:
| Main Authors: | Xīn Gào, Chen Zhao, Junting Yang, Ziming Yang, Jingnan Feng, Siyan Zhan, Dongsheng Fan, Zhike Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01239-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023
by: Yi Deun Jeong, et al.
Published: (2024-10-01) -
Neurosarcoidosis Presenting as Guillain-Barre Syndrome
by: Abhishek Juneja, et al.
Published: (2021-01-01) -
Systemic lupus erythematosus presenting as Guillain‒Barre syndrome
by: Arundhati Das, et al.
Published: (2022-01-01) -
Guillain-Barré Syndrome Unmasking Asymptomatic Peripheral Spondyloarthritis
by: Harleen Kaur, et al.
Published: (2021-01-01) -
Clinical Spectrum and Outcome of Guillain-Barré Syndrome with Plasmapheresis
by: Safia Bano, et al.
Published: (2022-10-01)